CN Patent
CN111757878B — 一种哒嗪类衍生物抑制剂、其制备方法和应用
Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2023-07-28 · 3y expired
What this patent protects
本发明涉及一种哒嗪类衍生物抑制剂、其制备方法和应用。特别地,本发明涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物,及其在制备TYK2抑制剂药物中的应用。
USPTO Abstract
本发明涉及一种哒嗪类衍生物抑制剂、其制备方法和应用。特别地,本发明涉及通式(I)所示的化合物、其制备方法及含有该化合物的药物组合物,及其在制备TYK2抑制剂药物中的应用。
Drugs covered by this patent
- Sotyktu (DEUCRAVACITINIB) · Bristol-Myers Squibb
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.